SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company: Sensei Biotherapeutics, Inc.
Filed: November 21, 2022
Accession Number: 0001193805-22-001584

View Document ↗ View on SEC.gov ↗